Register now: Protagenic Therapeutics, Inc. (PTIX) is hosting a key opinion leader (KOL) webinar focused on PT00114 for the regulation of stress in patients with Depression, PTSD, Anxiety and Addiction on Tuesday, July 13 at 10:00AM ET. Register here: protagenic.com/webinar-on-dep…

A recent investor forum with Q&A featuring Dr. Maurizio Fava, principal investigator of the planned PT00114 Phase I/IIa clinical trial, is now available for viewing here: protagenic.com/webinar-on-dep…

Pioneering Neuronal Health: Aiming to be an innovative, safe, and effective treatment platform that regulates stress response and restores healthy brain function. Introducing the brand new Protagenic Website: protagenic.com

Protagenic's CMO, Bob Stein, MD, PhD is participating in the Advances in Mental Health Virtual Conference, presented by Maxim Group LLC, hosted by M-Vest, on Sept. 22nd, 9am – 2 pm ET. This conference will be live on M-Vest. To attend, sign up to become an M-Vest member

Protagenic Therapeutics, Inc. (#PTIX) Virtual Science Review: A review of our programs designed for the treatment of patients with Depression, PTSD, Anxiety & Addiction Watch the full webinar here: protagenic.com/publications-m…